SCHEMBL5282035

SCHEMBL5282035

CC(C)=NN=c1scc(-c2cccc(O)c2)n1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.45
HSD17B1 P14061 7/20 0.38
HSD17B2 P37059 7/20 0.38
CYP3A4 P08684 3/20 0.36
CYP2C9 P11712 2/20 0.36
ABL1 P00519 1/20 0.35
FYN P06241 7/20 0.35
MKNK1 Q9BUB5 1/20 0.34
ATP4A P20648 1/20 0.34
ATP4B P51164 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5282033 1.00 RXFP1 (0.45) RXFP1HSD17B1HSD17B2CYP3A4CYP2C9
SCHEMBL5280844 0.85 IDO1 (0.40) RXFP1ABL1FYNATP4AATP4B
SCHEMBL5285390 0.85 ALDH1A1 (0.35) RXFP1ALDH1A1LMNAGAAMAPT
SCHEMBL5280840 0.85 IDO1 (0.40) RXFP1ABL1FYNATP4AATP4B
SCHEMBL5283771 0.84 SMN1; SMN2 (0.43) RXFP1NPC1ALDH1A1LMNAGAA
SCHEMBL5283764 0.84 SMN1; SMN2 (0.43) RXFP1NPC1ALDH1A1LMNAGAA
SCHEMBL5278228 0.82 SMN1; SMN2 (0.41) RXFP1NPC1ALDH1A1LMNAGAA
SCHEMBL5280088 0.80 CA12 (0.47) NPC1ALDH1A1GAAMAPTMAPK1
SCHEMBL5280091 0.80 CA12 (0.47) NPC1ALDH1A1GAAMAPTMAPK1
SCHEMBL5288480 0.80 MAOA (0.41) NPC1ALDH1A1MAPTRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP claimed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US claimed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP claimed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO claimed
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP disclosed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT RXFP1 4132/4885HSD17B1 1949/4885HSD17B2 2658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.